|
|
News Breaks | | | | November 28, 2012 | | 16:10 EDT |  | QGEN | QIAGEN gains FDA approval to market careHPV test in China
QIAGEN announced that China's State Food and Drug Administration has approved QIAGEN's careHPV Test and instrument platform. The careHPV Test is the first molecular diagnostic to screen for high risk human papillomavirus, or HPV, designed for low-resource clinical settings, such as areas lacking electricity, water or modern laboratory infrastructure. QIAGEN expects to announce the product availability of careHPV in China in January 2013, followed by India later in 2013 and other emerging markets as approvals are received. QIAGEN will introduce the careHPV Test and key data of its performance at the International Papillomavirus, or IPV, conference, starting November 30 in Puerto Rico. | |
|
News For QGEN From The Last 14 Days Check below for free stories on QGEN the last two weeks. |
|
|
| There are no results for QGEN |
|
|
|
|
|
|
